The Beta Nu Omega chapter of Alpha Kappa Alpha Sorority hosted the 26th Annual Miss Fashionetta contest at the Joe L. Reed Acadome on Sunday afternoon.

Sponsored by Johnson Publishing Company, the tour of haute couture fashions makes a stop in the Capital City each year at the request of the local sorority -- one of more than 180 organizations around the country, in the Bahamas and the U.S.

Foamix and Intendis Sign License Agreement for the Development of a Dermatological Foam

Intendis GmbH and Foamix Ltd., the leader in the development of topical foam delivery systems, announced today that they have executed a worldwide license agreement for a dermatological foam. The agreement was signed following successful completion of Foamix's development of a novel alcohol-free foam.

Under the terms of the agreement, Intendis is to pay Foamix a signing fee and milestone payments, as well as royalties based on net sales.

"We are pleased to announce this license agreement with Foamix. Foamix has a proven track record of developing innovative dermatological foams and we are confident that this product will be an important addition to our range of products", said Prof. Dr. Wolfgang Kehr, President and CEO of Intendis.

"This agreement with Intendis, a leader in the field of dermatology, validates our expertise in the development of dermatological foams", said Foamix CEO, Dr.

CollaGenex Pharmaceuticals to Present at the Wachovia Securities 2007 Healthcare Conference

CollaGenex Pharmaceuticals, Inc. (NASDAQ:CGPI) today announced that Colin W. Stewart, president and chief executive officer, will present at the Wachovia Securities 2007 Healthcare Conference. The presentation is scheduled to begin at 2:00 p.m. EST on Tuesday, January 30, 2007, at the Langham Hotel in Boston, MA.

CollaGenex Pharmaceuticals, Inc. is a specialty pharmaceutical company currently focused on developing and marketing innovative proprietary medical therapies to the dermatology market.